Pelthos Therapeutics Inc (PTHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,655 | -5,417 | -1,968 | -7,955 | -6,029 |
| Depreciation Amortization | 1,401 | 259 | 94 | 692 | 616 |
| Accounts receivable | -7,940 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,031 | N/A | N/A | N/A | 558 |
| Other Working Capital | -1,854 | 3,179 | 755 | 35 | -615 |
| Other Operating Activity | 9,679 | 899 | 486 | 1,436 | 348 |
| Operating Cash Flow | $-16,338 | $-1,079 | $-632 | $-5,793 | $-5,122 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | 2,761 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $2,761 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 28,077 | 625 | 250 | 536 | 690 |
| Debt Repayment | -845 | N/A | N/A | -215 | -215 |
| Common Stock Issued | 85 | N/A | N/A | 5,972 | 5,972 |
| Common Stock Repurchased | N/A | N/A | N/A | -167 | -166 |
| Other Financing Activity | 0 | 0 | 0 | 83 | 0 |
| Financing Cash Flow | $27,317 | $625 | $250 | $6,210 | $6,281 |
| Beginning Cash Position | 513 | 513 | 513 | 96 | 96 |
| End Cash Position | 14,253 | 59 | 131 | 513 | 1,255 |
| Net Cash Flow | $13,740 | $-454 | $-382 | $417 | $1,159 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,338 | -1,079 | -632 | -5,793 | -5,122 |
| Free Cash Flow | -16,338 | -1,079 | -632 | -5,793 | -5,122 |